A colonoscopy lets a doctor examine the entire lining of your large intestine and remove precancerous growths called polyps before they ever become cancer. Most colon polyps take 10 years or longer to develop into colorectal cancer, which means a single screening can interrupt that process years before you’d ever have symptoms. Current guidelines recommend that average-risk adults start screening at age 45 and repeat every 10 years if no problems are found.
Catching Polyps Before They Become Cancer
Colorectal cancer almost always starts as a small, harmless-looking polyp on the inner wall of the colon or rectum. These polyps grow slowly. The most common pathway from polyp to cancer takes a decade or more, giving you a long window to find and remove them. A less common but faster pathway can produce cancer in as little as one to three years, which is one reason people at higher risk need more frequent screening.
During a colonoscopy, the doctor can spot these polyps and remove them on the spot, a procedure called polypectomy. That removal is the key advantage: no other screening test can find and treat precancerous growths in the same visit. A large trial published in the New England Journal of Medicine found that people invited to undergo screening colonoscopy had an 18% lower risk of developing colorectal cancer over the following 10 years compared to those who received no screening.
Investigating Symptoms That Need Answers
Screening colonoscopies are for people with no symptoms. But colonoscopy also serves as a diagnostic tool when something is already wrong. Your doctor may recommend one if you’re experiencing:
- Rectal bleeding or blood in your stool
- Unexplained weight loss
- Persistent changes in bowel habits, such as new constipation or diarrhea lasting weeks
- Chronic abdominal pain
- Iron deficiency anemia with no clear cause
- A positive stool test, meaning a non-invasive screening picked up hidden blood or abnormal DNA
In these cases, the colonoscopy isn’t just screening for cancer. It can identify inflammatory bowel disease, diverticular disease, ulcers, and other conditions that explain the symptoms and guide treatment.
Why No Other Test Fully Replaces It
Stool-based tests are a legitimate screening option if you’re at average risk, and they’re easier to do at home. But they have real limitations. The newest stool DNA test detects advanced precancerous polyps only about 43% of the time. The standard stool blood test (FIT) catches them roughly 33% of the time. Both tests are good at finding actual cancers, but they miss more than half of the dangerous polyps that haven’t turned cancerous yet.
If either stool test comes back positive, you’ll need a colonoscopy anyway to confirm and remove whatever triggered the result. Colonoscopy remains the only test that can both find and remove polyps in one procedure, which is why it’s considered the gold standard for colorectal cancer prevention, not just detection.
Who Needs Earlier or More Frequent Screening
The every-10-years schedule applies to people with average risk starting at age 45. Several factors move that timeline up significantly.
People with Lynch syndrome, an inherited condition that dramatically raises colorectal cancer risk, are typically advised to begin colonoscopies between ages 20 and 25, with repeat screenings every one to two years. For those who carry lower-risk gene variants within Lynch syndrome, screening may start at 30 to 35, with intervals stretched to every one to three years depending on the specific gene involved.
If you have inflammatory bowel disease (ulcerative colitis or Crohn’s disease affecting the colon), surveillance colonoscopy generally begins 8 to 10 years after diagnosis. After that point, guidelines recommend repeat colonoscopies every one to three years, because chronic inflammation in the colon significantly raises cancer risk over time.
A strong family history of colorectal cancer, even without a known genetic syndrome, also typically moves your first screening to an earlier age, often 10 years before the age your relative was diagnosed.
What Happens If Your Prep Is Poor
The bowel preparation, the laxative drink you take the day before, is the part most people dread. But how well it works directly affects whether the procedure can do its job. When prep quality drops from excellent to poor, the miss rate for advanced precancerous polyps jumps from around 9% to 37% or higher. Even a “fair” prep raises the advanced polyp miss rate to roughly 18%, double that of an excellent prep.
If your colon isn’t clean enough for the doctor to see the lining clearly, you may need to come back and repeat the entire process sooner than you otherwise would. Following the prep instructions exactly, including the dietary restrictions and the timing of each dose, is the single most important thing you can do to make the procedure effective.
Risks Are Low but Real
Colonoscopy is invasive, which is its main drawback compared to stool tests. The most serious complication is perforation, a small tear in the colon wall. Population-level data puts this risk at about 2 per 1,000 procedures (0.2%). Bleeding after polyp removal is another possibility, though it’s usually minor and resolves on its own. The sedation used during the procedure carries its own small risks, particularly for people with heart or lung conditions.
For most people, the benefit of catching and removing precancerous polyps far outweighs these risks, especially given that colorectal cancer is the second leading cause of cancer death in the United States when men and women are combined. The procedure itself typically takes 30 to 60 minutes, and most people return to normal activities the next day.
Quality Varies Between Doctors
Not all colonoscopies are created equal. The key quality measure is something called the adenoma detection rate: the percentage of screening colonoscopies in which the doctor finds at least one precancerous polyp. The minimum benchmark is 25% overall (30% in men, 20% in women). Doctors who fall below this threshold miss polyps at higher rates, which means their patients are more likely to develop cancer between screenings. If you’re scheduling a colonoscopy, it’s reasonable to ask your gastroenterologist about their detection rate.